⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of R&D Pharma (ООО «ЭР ЭНД ДИ ФАРМА») and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
R&D Pharma (ООО «ЭР ЭНД ДИ ФАРМА»)
↗Moscow, Russia
R&D Pharma is a Russian contract research organization (CRO) founded in 2009 that specializes in preclinical and clinical research, as well as the registration of medicinal products. The company provides comprehensive regulatory and operational support for pharmaceutical companies, including those without a local presence in Russia.
The organization maintains an extensive network of partners, including clinical centers, preclinical facilities, and bioanalytical/pharmacokinetic laboratories. They are experienced in managing complex drug development projects across various therapeutic areas, including cardiology, neurology, and gastroenterology.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:CRO
Sub-Industry:Clinical Research and Regulatory Services
SIZE & FINANCIALS
Employees:51-200
Founded:2009
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Regulatory/Clinical Support
Modalities:Small molecule, Vaccines
Active Trials:3
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Various Russian clinical centers, Preclinical and bioanalytical laboratories
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Roman V. Ivanov - General Director
Roman Y. Maksvitis - Medical Research Director
Scientific Founders:Roman V. Ivanov, Roman Y. Maksvitis
LINKS
Website:rdpharma.ru
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with R&D Pharma (ООО «ЭР ЭНД ДИ ФАРМА»). The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.